Vaxart Inc (VXRT)
0.8229
+0.01
(+1.11%)
USD |
NASDAQ |
May 31, 16:00
0.8263
0.00 (0.00%)
After-Hours: 20:00
Vaxart Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2015 | 23.70M |
| June 30, 2015 | 21.00M |
| March 31, 2015 | 15.60M |
| December 31, 2014 | 20.20M |
| September 30, 2014 | 15.00M |
| June 30, 2014 | 17.60M |
| March 31, 2014 | 21.18M |
| December 31, 2013 | 19.39M |
| September 30, 2013 | 15.58M |
| June 30, 2013 | 14.62M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 5.459M |
| December 31, 2011 | 13.38M |
| September 30, 2011 | 14.74M |
| June 30, 2011 | 25.49M |
| March 31, 2011 | 26.53M |
| December 31, 2010 | 31.05M |
| September 30, 2010 | 37.30M |
| June 30, 2010 | 25.81M |
| March 31, 2010 | 21.57M |
| December 31, 2009 | 8.501M |
| September 30, 2009 |
| Date | Value |
|---|---|
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | -1.309M |
| June 30, 2005 | 16.11M |
| March 31, 2005 | 36.60M |
| December 31, 2004 | 50.16M |
| September 30, 2004 | 122.50M |
| June 30, 2004 | 117.13M |
| March 31, 2004 | 101.15M |
| December 31, 2003 | 95.22M |
| September 30, 2003 | 82.00M |
| June 30, 2003 | 76.59M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Novavax Inc | 424.85M |
| Allogene Therapeutics Inc | -- |
| Inovio Pharmaceuticals Inc | -- |
| Stereotaxis Inc | 14.95M |
| Arcturus Therapeutics Holdings Inc | -- |